Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H13N3O2 |
| Molecular Weight | 195.2184 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1C(=O)C=C(N)N(CC=C)C1=O
InChI
InChIKey=NGXUUAFYUCOICP-UHFFFAOYSA-N
InChI=1S/C9H13N3O2/c1-3-5-12-7(10)6-8(13)11(4-2)9(12)14/h3,6H,1,4-5,10H2,2H3
| Molecular Formula | C9H13N3O2 |
| Molecular Weight | 195.2184 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
800 mg 1 times / day multiple, oral Dose: 800 mg, 1 times / day Route: oral Route: multiple Dose: 800 mg, 1 times / day Sources: |
unhealthy |
Disc. AE: Nausea, Vomiting... Other AEs: Diarrhoea, Epigastric pain... AEs leading to discontinuation/dose reduction: Nausea (3 patients) Other AEs:Vomiting (3 patients) Diarrhoea (mild, 1 patient) Sources: Epigastric pain (1 patient) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Epigastric pain | 1 patient | 800 mg 1 times / day multiple, oral Dose: 800 mg, 1 times / day Route: oral Route: multiple Dose: 800 mg, 1 times / day Sources: |
unhealthy |
| Nausea | 3 patients Disc. AE |
800 mg 1 times / day multiple, oral Dose: 800 mg, 1 times / day Route: oral Route: multiple Dose: 800 mg, 1 times / day Sources: |
unhealthy |
| Vomiting | 3 patients Disc. AE |
800 mg 1 times / day multiple, oral Dose: 800 mg, 1 times / day Route: oral Route: multiple Dose: 800 mg, 1 times / day Sources: |
unhealthy |
| Diarrhoea | mild, 1 patient | 800 mg 1 times / day multiple, oral Dose: 800 mg, 1 times / day Route: oral Route: multiple Dose: 800 mg, 1 times / day Sources: |
unhealthy |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Laboratory and clinical observations on three similar diuretic agents: aminophylline, aminometradine (mictine) and aminoisometradine (rolicton). | 1957-12 |
|
| Current therapeutics. CVIII. Aminometradine. | 1956-12 |
|
| AMINOMETRADINE. | 1956-09-08 |
|
| Therapeutic and toxic effects of enteric-coated aminometramide. | 1956-08 |
|
| Aminometradine in treatment of congestive heart failure. | 1956-05-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:52:19 GMT 2025
by
admin
on
Mon Mar 31 17:52:19 GMT 2025
|
| Record UNII |
PPM8SX5Q3V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C448
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
PPM8SX5Q3V
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
555
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
AMINOMETRADINE
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
169
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
642-44-4
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
1440266
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
PPM8SX5Q3V
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
SUB05441MIG
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104036
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
12551
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
DTXSID00214403
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
211-384-6
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
C76645
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
100000087207
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
m1007
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |